Oura Blood Pressure Profile Study

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Final enrollment: 382200 participants (planned 2000000)
    • Primary completion date changed from estimate of May 2027 to Aug 12, 2026
    • Eligibility criteria expanded, about 9 words
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2025 to Dec 17, 2025
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Ouraring Inc.
2 trials monitored
See all monitored trials
Hypertension
1,935 trials monitored
See 96 trials at risk
The proposed study is designed as a prospective, single-arm, observational, non-significant risk device study to evaluate the performance of Oura's investigational Blood Pressure Profile algorithm in identifying signs of hypertension.
Trial Details
NCT Number NCT07267871
Lead Sponsor Ouraring Inc.
Conditions
(from sponsor)		 Hypertension, High Blood Pressure
Related terms Hypertension
Enrollment 382,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov